TickerStat.comwe like data

Niki BioSolutions, Inc. (NIKI)

Price$6.58Cached quote
NIKINasdaq
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

9 annual periodsNewest to oldest
202520242023202220212020201920182017
Revenue$0$0$431,378$1.3M$1.5M————
Gross profit$0$0$10,566$80,065$81,854————
Gross margin——2.45%6.18%5.31%————
Research & development$352,879$2.2M$5.2M$9.2M$10.9M$11.6M$6.9M$3.1M$2.6M
Operating expenses$1.8M$3.9M$11.2M$18.8M$20.7M$21.2M$18.7M$10.7M$5.7M
Operating income−$1.8M−$3.0M−$10.7M−$17.5M−$19.2M————
Operating margin——−2,486.04%−1,351.13%−1,245.80%————
EBITDA−$1.8M−$2.7M−$9.6M−$16.3M−$18.0M————
EBITDA margin——−2,225.19%−1,257.95%−1,168.45%————
Net income−$1.4M−$4.3M−$2.8M−$9.8M−$25.0M$4.9M−$20.1M−$14.8M−$2.5M
Net profit margin——−654.80%−756.20%−1,624.64%————
Basic EPSper basic share-$0.19-$0.78-$0.62-$2.75-$7.15$2.03-$0.64-$0.53-$0.09
Diluted EPSper diluted share-$0.19-$0.78-$0.62-$2.75-$7.15$2.00-$0.64-$0.53-$0.09
Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about NIKI yet. Start the conversation.

Write the first post